スニチニブリンゴ酸塩の世界市場レポート2020

• 英文タイトル：Global Sunitinib Malate (CAS：341031-54-7) Sales Market Report 2020

• レポートコード：MRC2102QY14379 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界のスニチニブリンゴ酸塩市場について種類別（純度99％以上、純度98％以上、純度97％以上）、用途別（進行性腎がん、GIST（消化管間質腫瘍）、膵神経内分泌腫瘍）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・スニチニブリンゴ酸塩市場の概要 ・世界の主要地域別スニチニブリンゴ酸塩市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のスニチニブリンゴ酸塩市場規模2015-2026：種類別（純度99％以上、純度98％以上、純度97％以上） ・世界のスニチニブリンゴ酸塩市場規模2015-2026：用途別（進行性腎がん、GIST（消化管間質腫瘍）、膵神経内分泌腫瘍） ・スニチニブリンゴ酸塩の米国市場規模2015-2020 ・スニチニブリンゴ酸塩のヨーロッパ市場規模2015-2020 ・スニチニブリンゴ酸塩の中国市場規模2015-2020 ・スニチニブリンゴ酸塩の日本市場規模2015-2020 ・スニチニブリンゴ酸塩の東南アジア市場規模2015-2020 ・スニチニブリンゴ酸塩のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・スニチニブリンゴ酸塩の製造コスト分析 ・販売チャネル、流通業者、顧客 ・スニチニブリンゴ酸塩の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Sunitinib Malate (CAS：341031-54-7) Market
The global Sunitinib Malate (CAS：341031-54-7) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Sunitinib Malate (CAS：341031-54-7) Scope and Market Size
The global Sunitinib Malate (CAS：341031-54-7) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sunitinib Malate (CAS：341031-54-7) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Sunitinib Malate (CAS：341031-54-7) market is segmented into
Purity Above 99%
Purity Above 98%
Purity Above 97%

Segment by Application, the Sunitinib Malate (CAS：341031-54-7) market is segmented into
Advanced Kidney Cancer
GIST (Gastrointestinal Stromal Tumor)
Pancreatic Neuroendocrine Tumors

The Sunitinib Malate (CAS：341031-54-7) market is analysed and market size information is provided by regions (countries). Segment by Application, the Sunitinib Malate (CAS：341031-54-7) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Sunitinib Malate (CAS：341031-54-7) Market Share Analysis
Sunitinib Malate (CAS：341031-54-7) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sunitinib Malate (CAS：341031-54-7) business, the date to enter into the Sunitinib Malate (CAS：341031-54-7) market, Sunitinib Malate (CAS：341031-54-7) product introduction, recent developments, etc.

The major vendors covered:
Pfizer Sutent
Topcare pharmaceutical Co., Ltd
Nanjing First Pharmaceutical Co., Ltd.
J&K Scientific
Target Molecule Corp.

レポート目次

---

1 Sunitinib Malate (CAS：341031-54-7) Market Overview
1.1 Sunitinib Malate (CAS：341031-54-7) Product Scope
1.2 Sunitinib Malate (CAS：341031-54-7) Segment by Type
1.2.1 Global Sunitinib Malate (CAS：341031-54-7) Sales by Type (2020-2026)
1.2.2 Purity Above 99%
1.2.3 Purity Above 98%
1.2.4 Purity Above 97%
1.3 Sunitinib Malate (CAS：341031-54-7) Segment by Application
1.3.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Comparison by Application (2020-2026)
1.3.2 Advanced Kidney Cancer
1.3.3 GIST (Gastrointestinal Stromal Tumor)
1.3.4 Pancreatic Neuroendocrine Tumors
1.4 Sunitinib Malate (CAS：341031-54-7) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Growth Rate (2015-2026)
1.4.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue and Growth Rate (2015-2026)
1.4.3 Global Sunitinib Malate (CAS：341031-54-7) Price Trends (2015-2026)

2 Sunitinib Malate (CAS：341031-54-7) Estimate and Forecast by Region
2.1 Global Sunitinib Malate (CAS：341031-54-7) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Sunitinib Malate (CAS：341031-54-7) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Region (2015-2020)
2.2.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Market Share by Region (2015-2020)
2.3 Global Sunitinib Malate (CAS：341031-54-7) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
2.4.2 Europe Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
2.4.3 China Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
2.4.4 Japan Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
2.4.6 India Sunitinib Malate (CAS：341031-54-7) Estimates and Projections (2015-2026)
3 Global Sunitinib Malate (CAS：341031-54-7) Competition Landscape by Players
3.1 Global Top Sunitinib Malate (CAS：341031-54-7) Players by Sales (2015-2020)
3.2 Global Top Sunitinib Malate (CAS：341031-54-7) Players by Revenue (2015-2020)
3.3 Global Sunitinib Malate (CAS：341031-54-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sunitinib Malate (CAS：341031-54-7) as of 2019)
3.4 Global Sunitinib Malate (CAS：341031-54-7) Average Price by Company (2015-2020)
3.5 Manufacturers Sunitinib Malate (CAS：341031-54-7) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Sunitinib Malate (CAS：341031-54-7) Players (Opinion Leaders)
4 Global Sunitinib Malate (CAS：341031-54-7) Market Size by Type
4.1 Global Sunitinib Malate (CAS：341031-54-7) Historic Market Review by Type (2015-2020)
4.1.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
4.1.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Market Share by Type (2015-2020)
4.1.3 Global Sunitinib Malate (CAS：341031-54-7) Price by Type (2015-2020)
4.2 Global Sunitinib Malate (CAS：341031-54-7) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Forecast by Type (2021-2026)
4.2.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Forecast by Type (2021-2026)
4.2.3 Global Sunitinib Malate (CAS：341031-54-7) Price Forecast by Type (2021-2026)
5 Global Sunitinib Malate (CAS：341031-54-7) Market Size by Application
5.1 Global Sunitinib Malate (CAS：341031-54-7) Historic Market Review by Application (2015-2020)
5.1.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
5.1.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Market Share by Application (2015-2020)
5.1.3 Global Sunitinib Malate (CAS：341031-54-7) Price by Application (2015-2020)
5.2 Global Sunitinib Malate (CAS：341031-54-7) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Sunitinib Malate (CAS：341031-54-7) Sales Forecast by Application (2021-2026)
5.2.2 Global Sunitinib Malate (CAS：341031-54-7) Revenue Forecast by Application (2021-2026)
5.2.3 Global Sunitinib Malate (CAS：341031-54-7) Price Forecast by Application (2021-2026)

6 United States Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
6.1 United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
6.2 United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
6.3 United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

7 Europe Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
7.1 Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
7.2 Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
7.3 Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

8 China Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
8.1 China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
8.2 China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
8.3 China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

9 Japan Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
9.1 Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (3015-3030)
9.2 Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
9.3 Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

10 Southeast Asia Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
10.1 Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

11 India Sunitinib Malate (CAS：341031-54-7) Market Facts & Figures
11.1 India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
11.2 India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
11.3 India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Sunitinib Malate (CAS：341031-54-7) Business
12.1 Pfizer Sutent
12.1.1 Pfizer Sutent Corporation Information
12.1.2 Pfizer Sutent Business Overview
12.1.3 Pfizer Sutent Sunitinib Malate (CAS：341031-54-7) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Sutent Sunitinib Malate (CAS：341031-54-7) Products Offered
12.1.5 Pfizer Sutent Recent Development
12.2 Topcare pharmaceutical Co., Ltd
12.2.1 Topcare pharmaceutical Co., Ltd Corporation Information
12.2.2 Topcare pharmaceutical Co., Ltd Business Overview
12.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS：341031-54-7) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS：341031-54-7) Products Offered
12.2.5 Topcare pharmaceutical Co., Ltd Recent Development
12.3 Nanjing First Pharmaceutical Co., Ltd.
12.3.1 Nanjing First Pharmaceutical Co., Ltd. Corporation Information
12.3.2 Nanjing First Pharmaceutical Co., Ltd. Business Overview
12.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS：341031-54-7) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS：341031-54-7) Products Offered
12.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Development
12.4 J&K Scientific
12.4.1 J&K Scientific Corporation Information
12.4.2 J&K Scientific Business Overview
12.4.3 J&K Scientific Sunitinib Malate (CAS：341031-54-7) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 J&K Scientific Sunitinib Malate (CAS：341031-54-7) Products Offered
12.4.5 J&K Scientific Recent Development
12.5 Target Molecule Corp.
12.5.1 Target Molecule Corp. Corporation Information
12.5.2 Target Molecule Corp. Business Overview
12.5.3 Target Molecule Corp. Sunitinib Malate (CAS：341031-54-7) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Target Molecule Corp. Sunitinib Malate (CAS：341031-54-7) Products Offered
12.5.5 Target Molecule Corp. Recent Development
…

13 Sunitinib Malate (CAS：341031-54-7) Manufacturing Cost Analysis
13.1 Sunitinib Malate (CAS：341031-54-7) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sunitinib Malate (CAS：341031-54-7)
13.4 Sunitinib Malate (CAS：341031-54-7) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sunitinib Malate (CAS：341031-54-7) Distributors List
14.3 Sunitinib Malate (CAS：341031-54-7) Customers

15 Market Dynamics
15.1 Sunitinib Malate (CAS：341031-54-7) Market Trends
15.2 Sunitinib Malate (CAS：341031-54-7) Opportunities and Drivers
15.3 Sunitinib Malate (CAS：341031-54-7) Market Challenges
15.4 Sunitinib Malate (CAS：341031-54-7) Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Sunitinib Malate (CAS：341031-54-7) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Region (2015-2020)
Table 5. Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Region (2015-2020)
Table 6. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Region (2015-2020)
Table 8. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Sunitinib Malate (CAS：341031-54-7) (K MT) of Key Companies (2015-2020)
Table 13. Global Sunitinib Malate (CAS：341031-54-7) Sales Share by Company (2015-2020)
Table 14. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Company (2015-2020)
Table 16. Global Sunitinib Malate (CAS：341031-54-7) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sunitinib Malate (CAS：341031-54-7) as of 2019)
Table 17. Global Sunitinib Malate (CAS：341031-54-7) Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Sunitinib Malate (CAS：341031-54-7) Manufacturing Sites and Area Served
Table 19. Manufacturers Sunitinib Malate (CAS：341031-54-7) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Sunitinib Malate (CAS：341031-54-7) Players
Table 22. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 23. Global Sunitinib Malate (CAS：341031-54-7) Sales Share by Type (2015-2020)
Table 24. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Sunitinib Malate (CAS：341031-54-7) Price (K MT) by Type (2015-2020)
Table 26. Global Sunitinib Malate (CAS：341031-54-7) Sales Share by Type (2021-2026)
Table 27. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Type (2021-2026)
Table 29. Global Sunitinib Malate (CAS：341031-54-7) Price (K MT) by Type (2021-2026)
Table 30. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 31. Global Sunitinib Malate (CAS：341031-54-7) Sales Share by Application (2015-2020)
Table 32. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Sunitinib Malate (CAS：341031-54-7) Price (K MT) by Application (2015-2020)
Table 34. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2021-2026)
Table 35. Global Sunitinib Malate (CAS：341031-54-7) Sales Share by Application (2021-2026)
Table 36. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Application (2021-2026)
Table 38. Global Sunitinib Malate (CAS：341031-54-7) Price (K MT) by Application (2021-2026)
Table 39. United States Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 40. United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 41. United States Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 42. United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 43. United States Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 44. United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
Table 45. Europe Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 46. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 47. Europe Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 48. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 49. Europe Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 50. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 51. China Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 52. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 53. China Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 54. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 55. China Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 56. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
Table 57. Japan Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 58. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 59. Japan Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 60. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 61. Japan Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 62. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
Table 69. India Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Company (2015-2020)
Table 70. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company (2015-2020)
Table 71. India Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Type (2015-2020)
Table 72. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type (2015-2020)
Table 73. India Sunitinib Malate (CAS：341031-54-7) Sales (K MT) by Application (2015-2020)
Table 74. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application (2015-2020)
Table 75. Pfizer Sutent Corporation Information
Table 76. Pfizer Sutent Description and Business Overview
Table 77. Pfizer Sutent Sunitinib Malate (CAS：341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Sutent Sunitinib Malate (CAS：341031-54-7) Product
Table 79. Pfizer Sutent Recent Development
Table 80. Topcare pharmaceutical Co., Ltd Corporation Information
Table 81. Topcare pharmaceutical Co., Ltd Description and Business Overview
Table 82. Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS：341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Topcare pharmaceutical Co., Ltd Sunitinib Malate (CAS：341031-54-7) Product
Table 84. Topcare pharmaceutical Co., Ltd Recent Development
Table 85. Nanjing First Pharmaceutical Co., Ltd. Corporation Information
Table 86. Nanjing First Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS：341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate (CAS：341031-54-7) Product
Table 89. Nanjing First Pharmaceutical Co., Ltd. Recent Development
Table 90. J&K Scientific Corporation Information
Table 91. J&K Scientific Description and Business Overview
Table 92. J&K Scientific Sunitinib Malate (CAS：341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. J&K Scientific Sunitinib Malate (CAS：341031-54-7) Product
Table 94. J&K Scientific Recent Development
Table 95. Target Molecule Corp. Corporation Information
Table 96. Target Molecule Corp. Description and Business Overview
Table 97. Target Molecule Corp. Sunitinib Malate (CAS：341031-54-7) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Target Molecule Corp. Sunitinib Malate (CAS：341031-54-7) Product
Table 99. Target Molecule Corp. Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Sunitinib Malate (CAS：341031-54-7) Distributors List
Table 103. Sunitinib Malate (CAS：341031-54-7) Customers List
Table 104. Sunitinib Malate (CAS：341031-54-7) Market Key Trends
Table 105. Sunitinib Malate (CAS：341031-54-7) Key Opportunities and Drivers
Table 106. Sunitinib Malate (CAS：341031-54-7) Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Sunitinib Malate (CAS：341031-54-7) Product Picture
Figure 2. Global Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sunitinib Malate (CAS：341031-54-7) Market Share by Application in 2020 & 2026
Figure 6. Advanced Kidney Cancer Examples
Figure 7. GIST (Gastrointestinal Stromal Tumor) Examples
Figure 8. Pancreatic Neuroendocrine Tumors Examples
Figure 9. Global Sunitinib Malate (CAS：341031-54-7) Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Sunitinib Malate (CAS：341031-54-7) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Sunitinib Malate (CAS：341031-54-7) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Sunitinib Malate (CAS：341031-54-7) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Sunitinib Malate (CAS：341031-54-7) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Sunitinib Malate (CAS：341031-54-7) Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Sunitinib Malate (CAS：341031-54-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Sunitinib Malate (CAS：341031-54-7) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Sunitinib Malate (CAS：341031-54-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Sunitinib Malate (CAS：341031-54-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Sunitinib Malate (CAS：341031-54-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Sunitinib Malate (CAS：341031-54-7) Players Market Share by Revenue in Sunitinib Malate (CAS：341031-54-7) 2015 & 2019
Figure 27. Sunitinib Malate (CAS：341031-54-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Type (2015-2020)
Figure 29. Global Sunitinib Malate (CAS：341031-54-7) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Sunitinib Malate (CAS：341031-54-7) Revenue Share by Application (2015-2020)
Figure 31. Global Sunitinib Malate (CAS：341031-54-7) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 33. United States Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 34. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company in 2019
Figure 35. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 36. Europe Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application in 2019
Figure 37. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company in 2019
Figure 38. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 39. China Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application in 2019
Figure 40. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company in 2019
Figure 41. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 42. Japan Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application in 2019
Figure 46. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Company in 2019
Figure 47. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Type in 2019
Figure 48. India Sunitinib Malate (CAS：341031-54-7) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Sunitinib Malate (CAS：341031-54-7)
Figure 51. Manufacturing Process Analysis of Sunitinib Malate (CAS：341031-54-7)
Figure 52. Sunitinib Malate (CAS：341031-54-7) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

---